ArticleFrontiers in medicine2025
Comparison of two main orthokeratology lens designs in effectiveness and safety for myopia control in different ages.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A personalized simulation framework for optimizing orthokeratology lens parameters based on 3D corneal modeling and biomechanical analysis.Frontiers in bioengineering and biotechnology · 2026Article
- Association between peripheral retinal lesions and ocular biometric parameters in adults with mild-to-moderate myopia attending a refractive surgery clinic.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Myopia represents the most prevalent ocular condition among children and adolescents worldwide, exhibiting marked variations in prevalence across regions and ethnic groups. This study aimed to assess and compare the effectiveness and safety of two orthokeratology (OK) lens types-corneal refractive therapy (CRT) and vision shaping treatment (VST)-for controlling myopia progression across different age groups. Methods: A retrospective cohort analysis was performed on 105 pediatric patients (210 eyes; aged 8-16 years) clinically diagnosed with myopia who wore CRT or VST lenses for at least 12 months. Longitudinal evaluations included axial length (AL) progression, axial length-to-corneal curvature (AL/CR) ratio, corneal curvature, corneal eccentricity indices (e-values), and safety parameters. Results: CRT lenses markedly limited AL elongation and reduced corneal curvature flattening in participants younger than 13 years ( Conclusion: The results reveal age-dependent variations in effectiveness, supporting an individualized approach to OK lens selection for optimized myopia management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.